Open-Label, Single-Arm, Multi-Center, Pharmacokinetic, Safety and Tolerability Study of Levetiracetam Intravenous Infusion in Children (4 - 16 Years Old) With Epilepsy.
Phase of Trial: Phase II
Latest Information Update: 30 Oct 2014
At a glance
- Drugs Levetiracetam (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Pharmacokinetics
- Sponsors UCB
- 28 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Feb 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Aug 2009 Planned end date changed from 1 Jan 2010 to 1 Feb 2010 as reported by ClinicalTrials.gov.